Mary Ann Dillahunty - Principal, Fish & Richardson
Mary Ann Dillahunty is a Principal of Fish & Richardson P.C. Her practice emphasizes patent prosecution in the areas of biotechnology, pharmaceuticals, and chemistry, including related drug delivery devices, systems and apparatus. She works closely with clients ranging from start-ups to big pharma to build and maintain a competitive patent position.
Ms. Dillahunty has extensive technical, research management, and legal experience in the pharmaceutical and biomedical industries, having worked for many years as a scientist, manager and attorney at both large and small pharmaceutical and biotechnology companies. A significant amount of Ms. Dillahunty's practice and experience is in interference proceedings.
Ping Hwung - Principal, Fish & Richardson
Ping Hwung's practice emphasizes patent prosecution in the areas of biotechnology and pharmaceutical inventions. She has technical experience as a postdoctoral fellow at Stanford University and Baylor College of Medicine. Ping holds a B.S. in Agricultural Chemistry, an M.S. in Microbiology and Immunology, a Ph.D. in Cell Biology and her J.D. from Boalt Hall School of Law at UC Berkeley. She is admitted to the bar in California and registered to practice before the United States Patent and Trademark Office. Ping has written and presented extensively on subjects relating to biological chemistry, molecular cell biology, immunpathology, and pharmaceuticals. She is fluent in Mandarin Chinese and is a member of the American Bar Association, the American Intellectual Property Law Association and the San Francisco Intellectual Property Law Association.
Kraig Anderson - Technology Specialist, Fish & Richardson
Kraig Anderson is a technology specialist at Fish & Richardson's Silicon Valley office. His practice supports patent prosecution in the areas of pharmaceuticals, biotechnology, chemistry, nanotechnology, materials science, and medical devices. Prior to coming to Fish & Richardson, Dr. Anderson spent three years at a Boston area law firm, where he drafted and prosecuted applications in technologies including small molecule pharmaceuticals, chemical syntheses, ion channel proteins, drug coated stents, bariatric implants, microfluidics, semiconductor sensors, and nanoscale quantum effect devices.
Previously, as a consultant, he managed cross-disciplinary engineering teams to develop technologies in such areas as drug processing/delivery systems, DNA microarray scanners, handheld RFID readers, and medical devices. This work led to several patent applications, including one resulting in an issued patent to a DNA microarray scanner. As a senior member of the technical staff at Sandia National Laboratories, Dr. Anderson conducted experiments and programmed computer models of physicochemical aging processes in high explosives.
While still in graduate school at Caltech, Dr. Anderson co-founded a Hollywood-based, post-production special effects company, creating effects for nationally televised ad campaigns for clients such as Acura, Lexus, American Express, Nintendo, Teva, Miller Brewing, and the American Red Cross.